Newsroom – Page 3 – Qnovia

Have a Project in Mind? Say Hi!

+1 800 123 456 789

+1 800 123 654 987

Mon - Sun: 10am - 10pm

27 Division St, New York,
NY 10002, USA

grido@mail.com

Newsroom

Press Releases

Media

October 7, 2022

How Qnovia aims to use inhaled therapeutics for smoking cessation

October 4, 2022

Eyeing nicotine replacement market, Qnovia bags $17M to take inhaled delivery device into the clinic

October 4, 2022

Technology Networks

Qnovia, Inc. Raises $17 Million in Series A Funding To Advance Its Inhalable Therapeutics Pipeline

October 3, 2022

Richmond BizSense

Startup led by former Altria exec raises $17M to make inhaler for smokers who want to quit

October 3, 2022

Richmond BizSense

Startup led by former Altria exec raises $17M to make inhaler for smokers who want to quit

September 30, 2022

This Week in ‘Raises’: Triller Grabs $310M, GordonMD Lands $83M

September 29, 2022

Medtech Strategist

Qnovia: Pocket-Sized Vapor Nebulization

September 29, 2022

Becker's Hospital Review

Qnovia raises $17M

September 28, 2022

Drug Delivery Business

Qnovia raises $17M Series A for inhaled therapeutics pipeline

1
2
3
4

December 16, 2022

Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer

December 16, 2022

Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer

December 13, 2022

Brian Quigley, CEO at Qnovia Shares Insights on Respira Technologies Rebranded as Qnovia

November 16, 2022

Health Innovators – Brian Quigley and Mario Danek (Live from HLTH 2022)

November 8, 2022

Qnovia to Pursue UK Approval for Lead Asset QN-01 in Nicotine Replacement Therapy

November 2, 2022

The role of board members during a market downturn

November 2, 2022

The role of board members during a market downturn

October 19, 2022

Brian Quigley

October 7, 2022

How Qnovia aims to use inhaled therapeutics for smoking cessation

1
2
3
4
5